MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 186 filers reported holding MYRIAD GENETICS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $25,395,220 | +25.2% | 1,095,566 | +25.4% | 0.03% | +20.0% |
| Q1 2023 | $20,287,642 | +465106.2% | 873,338 | +190.6% | 0.02% | +316.7% |
| Q4 2022 | $4,361 | -99.9% | 300,560 | +35.6% | 0.01% | 0.0% |
| Q3 2022 | $4,230,000 | +34.2% | 221,679 | +27.8% | 0.01% | +50.0% |
| Q2 2022 | $3,151,000 | -23.2% | 173,410 | +6.5% | 0.00% | -20.0% |
| Q1 2022 | $4,102,000 | -10.9% | 162,795 | -2.4% | 0.01% | 0.0% |
| Q4 2021 | $4,602,000 | -29.2% | 166,734 | -17.2% | 0.01% | -28.6% |
| Q3 2021 | $6,502,000 | – | 201,376 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |